查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545532

白血球分离术的全球市场

Leukapheresis
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球白血球分离疗法市场预计将达到 1.437 亿美元

全球白血球分离疗法市场预计 2023 年为 8,970 万美元，预计到 2030 年将达到 1.437 亿美元，在 2023-2030 年分析期间复合年增长率为 7.0%。白血球分离设备是本报告分析的细分市场之一，复合年增长率为 7.1%，预计到分析期结束时将达到 1.226 亿美元。分析期间，抛弃式白血球分离术领域的复合年增长率预计为 6.0%。

美国市场预估成长2,460万美元，中国复合年增长率为6.5%

预计 2023 年美国白血球分离术市场规模将达 2,460 万美元。中国作为全球第二大经济体，预计2030年市场规模将达2,220万美元，2023-2030年分析期间复合年增长率为6.5%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 6.7% 和 5.6%。在欧洲，德国预计复合年增长率为 5.8%。

全球白血球去除疗法市场—主要趋势和驱动因素总结

什么是白血球去除术以及为什么它在治疗中变得越来越重要？

白血球去除术是一种选择性地从血液中去除白血球（白血球）的医疗程序，并且越来越多地用于治疗多种疾病，包括白血病、多发性骨髓瘤和自体免疫疾病。它越来越多地用于治疗多种疾病，包括白血病、多发性骨髓瘤和自体免疫疾病。这种方法越来越重要，因为它在治疗和研究环境中都发挥着重要作用。在治疗应用中，白血球去除术用于减少患有某些类型癌症的患者中危险的高白血球计数。在研究中，它用于收集白血球，用于开发和测试 CAR-T 细胞疗法等新治疗方法。随着对先进治疗方案的需求不断增加，白血球去除术正成为医疗领域的重要工具。

技术进展如何影响白血球分离术市场？

技术进步在白血球分离术市场的成长中发挥重要作用。更有效率、自动化的单采设备的开发使手术过程更安全、更快速、对患者更舒适。这些进步也使得白血球产量更高，这对于 CAR-T 细胞疗法等治疗的成功尤其重要。此外，白血球分离疗法的创新正在降低併发症的风险并改善患者的治疗结果。随着技术的不断发展，预计白血球分离疗法的功效和可及性将进一步提高并在临床和研究环境中得到采用。

白血球去除术在推动癌症治疗中扮演什么角色？

白血球分离术在癌症治疗的进展中发挥关键作用，特别是在 CAR-T 细胞疗法等免疫疗法的开发中。这种治疗方法使用白血球分离术从患者血液中去除 T 细胞，并对它们进行基因改造，以瞄准并摧毁癌细胞。这种个人化的癌症治疗方法已显示出有希望的结果，特别是对于患有某些类型的白血病和淋巴瘤的患者。此类治疗方法的日益成功增加了对白血球分离术的需求，白血球分离术是治疗过程中的关键步骤。随着更多免疫疗法的开发和核准，白血球分离术的使用预计将扩大并成为未来癌症治疗的重要组成部分。

推动白血球分离术市场成长的因素有哪些？

白血球分离术市场的成长是由多种因素推动的，例如癌症和自体免疫疾病盛行率的增加、血浆分离术技术的进步以及对个人化医疗的需求不断增长。另一个主要驱动因素是越来越多地采用免疫疗法，这种疗法利用白血球分离术来收穫免疫细胞。此外，以开发新治疗方法为重点的临床试验和研究活动的扩展正在推动对白血球分离手术的需求。随着医学界不断探索新治疗方法并改进现有治疗方法，白血球去除疗法市场预计将持续成长，因为它在现代医学的进步中发挥着重要作用。

受访企业范例（共12家）

  • Allcells LLC
  • Asahi Kasei Medical Co., Ltd.
  • BioIVT
  • Caltag Medsystems Limited
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Key Biologics, LLC.
  • MacoPharma SA
  • Ppa Research Group, Inc.
  • Precision Medicine Group, Inc.
  • StemCell Technologies Inc.
  • StemExpress
  • Terumo BCT, Inc.
  • Zenbio, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12997

Global Leukapheresis Market to Reach US$143.7 Million by 2030

The global market for Leukapheresis estimated at US$89.7 Million in the year 2023, is expected to reach US$143.7 Million by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Leukapheresis Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth in the Leukapheresis Disposables segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$24.6 Million While China is Forecast to Grow at 6.5% CAGR

The Leukapheresis market in the U.S. is estimated at US$24.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$22.2 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Leukapheresis Market - Key Trends & Drivers Summarized

What Is Leukapheresis and Why Is It Gaining Importance in Medical Treatments?

Leukapheresis is a medical procedure that involves the selective removal of white blood cells (leukocytes) from the blood, which is increasingly being used in the treatment of various diseases, including leukemia, multiple myeloma, and autoimmune disorders. This procedure is gaining importance due to its critical role in both therapeutic and research settings. In therapeutic applications, leukapheresis is used to reduce high white blood cell counts, which can be dangerous in certain cancer patients. In research, it is employed to collect leukocytes for use in developing and testing new therapies, such as CAR-T cell therapy. As the demand for advanced treatment options grows, leukapheresis is becoming an essential tool in the medical field.

How Are Technological Advancements Impacting the Leukapheresis Market?

Technological advancements are playing a significant role in the growth of the leukapheresis market. The development of more efficient and automated apheresis machines has made the procedure safer, faster, and more comfortable for patients. These advancements are also enabling higher yields of leukocytes, which is particularly important for the success of therapies like CAR-T cell therapy. Additionally, innovations in leukapheresis techniques are reducing the risk of complications and improving patient outcomes. As technology continues to evolve, it is expected to further enhance the efficacy and accessibility of leukapheresis, driving its adoption in both clinical and research settings.

What Role Does Leukapheresis Play in the Advancement of Cancer Therapies?

Leukapheresis is playing a crucial role in the advancement of cancer therapies, particularly in the development of immunotherapies such as CAR-T cell therapy. In this process, leukapheresis is used to collect T cells from the patient’s blood, which are then genetically modified to target and destroy cancer cells. This personalized approach to cancer treatment has shown promising results, especially in patients with certain types of leukemia and lymphoma. The increasing success of these therapies is driving demand for leukapheresis, as it is a critical step in the treatment process. As more immunotherapies are developed and approved, the use of leukapheresis is expected to expand, making it a key component in the future of cancer treatment.

What Factors Are Driving the Growth of the Leukapheresis Market?

The growth in the leukapheresis market is driven by several factors, including the increasing prevalence of cancer and autoimmune diseases, advancements in apheresis technology, and the rising demand for personalized medicine. The growing adoption of immunotherapies, which rely on leukapheresis for the collection of immune cells, is also a significant driver. Additionally, the expansion of clinical trials and research activities focused on developing new treatments is boosting the demand for leukapheresis procedures. As the medical community continues to explore new therapeutic applications and improve existing ones, the leukapheresis market is expected to experience sustained growth, driven by its critical role in advancing modern medical treatments.

Select Competitors (Total 12 Featured) -

  • Allcells LLC
  • Asahi Kasei Medical Co., Ltd.
  • BioIVT
  • Caltag Medsystems Limited
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Key Biologics, LLC.
  • MacoPharma SA
  • Ppa Research Group, Inc.
  • Precision Medicine Group, Inc.
  • StemCell Technologies Inc.
  • StemExpress
  • Terumo BCT, Inc.
  • Zenbio, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Leukapheresis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Apheresis Technology Propel Adoption of Leukapheresis in Therapeutic Applications
    • Shift Towards Personalized Medicine Expands Addressable Market for Leukapheresis
    • Rising Focus on Cell-Based Therapies and Immunotherapy Drives Adoption in Cancer Treatment
    • Rising Importance of Leukapheresis in Bone Marrow Transplantation Strengthens Demand
    • Growing Application of Leukapheresis in Stem Cell Collection Strengthens Market Demand
    • Technological Innovations in Leukapheresis Devices Enhance Efficiency and Patient Comfort
    • Expanding Use of Leukapheresis in Hematology and Oncology Generates New Opportunities
    • Push for High-Purity Cell Collection Fuels Demand in Clinical and Research Settings
    • Increasing Adoption of Leukapheresis in CAR-T Cell Therapy Accelerates Market Expansion
    • Technological Advancements in Automated and Continuous Flow Systems Expand Market Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Blood Component Providers & Blood Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Leukapheresis Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospital & Transfusion Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • JAPAN
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • CHINA
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • EUROPE
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • FRANCE
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • GERMANY
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030

IV. COMPETITION